Counselling sessions to quit tobacco use in schizophrenic patients

Impact of Motivational Enhancement Therapy in Cessation of Tobacco Use in Patients of Schizophrenia: An Interventional Study in Rural Central India - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070099

Enrollment

Registered

2024-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: Motivational Enhancement Therapy: Total duration: 1 year 0 months o days Control Intervention1: General population: As compared to normal subjects

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients who are clinically diagnosed to have Schizophrenia using the International Classification of Diseases 11th revision (ICD-11) research criteria and who are using tobacco in any form. b) Patients within the age group of 18 to 65 years. c) Patient should be able to give written informed consent.

Exclusion criteria

Exclusion criteria: a) Subjects not willing to give written informed consent. b) Patients who are acutely ill or not able to cooperate with the study c) Patients who have a history of developmental delay or any other major organic brain pathology. d) Patients who had past history of head injury.

Design outcomes

Primary

Measure	Time frame
To study the effect of motivational enhancement therapy in the process of cessation of tobacco use in patients with schizophrenia.Timepoint: The assessment will be done in 1 year	—

Secondary

Measure	Time frame
NilTimepoint: NA	—

Countries

India

Contacts

Public ContactDr P S Patil

Datta Meghe Institute of Higher Education and Research

dr.p.s.patil2012@gmail.com8999248979

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026